GSK plans to divest Lucozade and Ribena

25 April 2013 - Deborah Wilkes

Archived

GlaxoSmithKline plans to divest its Lucozade and Ribena nutritional drinks brands, as the company seeks to focus its Consumer Healthcare division on fast-growing priority brands and emerging markets.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: